Mariangela Di Trani

Comparison between Dasatinib-Blinatumomab Vs Ponatinib-Blinatumomab Chemo-Free Strategy for Newly Diagnosed Ph+ Acute Lymphoblastic Leukemia Patients. Preliminary Results of the Gimema ALLL2820 Trial

S. Chiaretti, L. Elia, P. Fazi, 2023, Blood.

Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?

R. Foà, A. Guarini, I. Della Starza, 2023, Frontiers in Oncology.

Circulating cell‐free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre‐analytical biases

R. Foà, S. Chiaretti, A. Guarini, 2022, Hematological oncology.